The firm said Jan. 18 that the system consists of a triangulation platform and an instrument for tissue piercing and approximation that can be affixed to an array of different endoscopes. The system enables suturing similar to what a laparoscopic approach allows, while using only natural orifices for an incisionless procedure.
Endo Tools Therapeutics said it’s planning a limited U.S. market release in the first half of 2022, with a wider release later in the year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.